1 December 2011 in Pediatrics
Standard pharmacologic closure of the patent ductus arteriosus currently involves the administration of 1 of 2 cyclooxygenase inhibitors: either indomethacin or ibuprofen. However, both of these drugs can be associated with potentially significant adverse effects. We present here the cases of 5 preterm infants (gestational age: 26–32 weeks; postnatal age: 3–35 days) with large, hemodynamically significant patent ductus arteriosus who had either failed or had contraindications to ibuprofen therapy. Each of these infants was treated with off-label oral paracetamol (15 mg/kg per dose every 6 hours). Ductal closure was achieved within 48 hours in all the treated infants. No toxicity was observed.
1 April 2012 in Seminars in Perinatology
1 September 1998 in Clinics in Perinatology
1 September 2002 in Journal of Pediatric Gastroenterology and Nutrition
1 December 1998 in Clinical Chemistry
Potentially toxic oxygen free radicals (OFRs) are generated continuously in neonates. Under physiological conditions, the human body has developed a complex network of antioxidant defenses sufficient to protect cells against oxidative damage. Oxidative stress results from a loss of this protective balance either because of overproduction of free radicals or because of inadequate antioxidant defenses. In prematures, the concentrations of most antioxidant enzymes are reduced, particularly during the early neonatal period ( 1). Impaired antioxidant defenses, occurring at a time when OFR production is both frequent and severe, render the premature neonate extremely susceptible to the development of OFR-mediated diseases.